Capping an extraordinary week of stock market losses that defied state intervention, China decided to double down on Saturday – hoping to avoid a “Black Monday” when trading resumes after the weekend.Meeting in Beijing, 21 major brokerage houses said they would contribute 120 billion yuan – the equivalent of $19.3 billion – to purchase blue-chip “exchange traded funds” to stabilize […]
Chinese stocks have been dropping recently and finally fell into bear-market territory on June 29, closing down 3.3%. The Shanghai composite has fallen over 21% so far from recent highs over the past two weeks as Chinese stocks have been under pressure after an explosion of margin buying over the past year.The stock drop on Monday came as a bit […]
The first half of 2015 has come and gone, and the long-running global bull market has significantly faltered.The Dow Jones Industrial Average fell 1.4% through the first six months of 2015, the first time the index has lost ground in that time frame since 2010. The S&P 500 eked out a 0.2% gain in the first half, its smallest H1 […]
By Michael Snyder, on July 2nd, 2015The second largest stock market in the entire world is collapsing right in front of our eyes. Since hitting a peak in June, the most important Chinese stock market index has plummeted by well over 20 percent, and more than 3 trillion dollars of “paper wealth” has been wiped out. Of course the […]
SummaryOvaScience, Sarpeta Therapeutics, Ziopharm Oncology and Keryx Biopharmaceuticals all have a short interest above 20%.
These small cap biotech companies provide attractive characteristics for fundamental weakness through liquidity needs, no revenue and a higher fail rate.
Given these common variables, there is strong indication that a large Marco short strategy has been put in place.
This large short position provides opportunities for contrarian […]
If you don’t want to lose your shirt this month, you have to buy the strongest trends on the market. Period.So today is your final installment of this week’s post-Greece craziness “search for strength” coverage.I showed you yesterday how health care and biotech stocks are the strongest and safest names on the market right now. And today I’m showing you […]
ShareShare on FacebookSharePinShare
Welcome to our new series — How did you get that job? — where we’ll run interviews with interesting people about their work and how they came to be doing it.When Brad Katsuyama came to the US in 2002 to run the trading desk for the Royal Bank of Canada, he thought he understood the game. If […]
By Nick Cunningham, a Washington DC-based writer on energy and environmental issues. You can follow him on twitter at @nickcunningham1. Originally published at OilPriceOil markets face a lot of downside risk – high crude oil inventories in both the U.S. and Europe, resilient production from U.S. shale, increasing output from OPEC, a nuclear deal with Iran, the turmoil in Greece […]
Advaxis, Inc. (NASDAQ:ADXS) is a biotechnology company which focuses on developing drug technology for treating Cancer. Alongside many other biotech stocks, Advaxis, Inc. (NASDAQ:ADXS)’s shares surged by 108% so far in 2015. However, in the last 30 days, the stock is down by 25%. Today, Advaxis is down by around 10%, after jumping by 17% on Tuesday. There have been […]
Share
Share
Email
URGENT: Today is the FINAL day to save $1,000 by pre-ordering your copy HERE of ‘Trading Tickers’…only a few spots left for Tim Grittani’s one-time only live trading webinar too…no more extensions, no whining after today, you have 24 hours from the time this blog post is published, go HERE, save a ton of money and get ready to learn […]
